Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,403,959
+$41,198 QoQ
Shares Held
13,403
-2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.59%
of 13F equity value
Holder Rank
#1,899
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLC Capital Advisors holds $21,615,806 across 11 Drug Manufacturers - General names. JNJ ranks #2 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
86,579 | $11,125,401 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
13,403 | $3,403,959 | |
| 3 | PFE |
Pfizer Inc
|
66,092 | $1,591,495 | |
| 4 | ABBV |
AbbVie Inc.
|
6,063 | $1,525,693 | |
| 5 | LLY |
ELI LILLY & Co
|
1,111 | $1,332,566 | |
| 6 | AMGN |
Amgen Inc
|
2,086 | $755,382 | |
| 7 | NVS |
Novartis AG
|
3,066 | $480,503 | |
| 8 | NVO |
Novo Nordisk A S
|
9,824 | $470,962 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,403,959 | 13,403 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,362,761 | 13,757 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,852,391 | 13,783 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,508,732 | 13,530 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $2,103,214 | 13,769 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,954,756 | 11,787 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,665,010 | 11,513 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,915,873 | 11,822 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,722,934 | 11,788 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,910,302 | 12,076 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,091,538 | 13,344 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,103,715 | 13,507 | Shares | Sole | 2024-01-18 | |
| 2023-06-30 | $2,304,369 | 13,922 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,219,910 | 14,322 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $2,740,548 | 15,514 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $2,663,094 | 16,302 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $3,033,645 | 17,090 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $3,022,303 | 17,053 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,917,256 | 17,053 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $2,787,328 | 17,259 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $2,843,247 | 17,259 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,919,349 | 17,763 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,789,717 | 17,726 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,580,834 | 17,335 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $2,514,745 | 17,882 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $1,977,964 | 15,084 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||